Mead Johnson Nutrition CO SVP Charles M. Urbain Sells 23,502 Shares (MJN)
Mead Johnson Nutrition CO (NYSE:MJN) SVP Charles M. Urbain sold 23,502 shares of the stock in a transaction dated Wednesday, June 18th. The stock was sold at an average price of $90.00, for a total value of $2,115,180.00. Following the completion of the sale, the senior vice president now directly owns 48,941 shares in the company, valued at approximately $4,404,690. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
Shares of Mead Johnson Nutrition CO (NYSE:MJN) traded up 0.61% on Thursday, hitting $92.06. 778,228 shares of the company’s stock traded hands. Mead Johnson Nutrition CO has a 1-year low of $66.80 and a 1-year high of $91.94. The stock’s 50-day moving average is $87.5 and its 200-day moving average is $83.76. The company has a market cap of $18.605 billion and a price-to-earnings ratio of 27.99.
Mead Johnson Nutrition CO (NYSE:MJN) last released its earnings data on Thursday, April 24th. The company reported $1.02 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.91 by $0.11. The company had revenue of $1.11 billion for the quarter, compared to the consensus estimate of $1.10 billion. During the same quarter in the prior year, the company posted $0.85 earnings per share. The company’s quarterly revenue was up 7.3% on a year-over-year basis. On average, analysts predict that Mead Johnson Nutrition CO will post $3.70 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which is scheduled for Thursday, July 3rd. Stockholders of record on Monday, June 23rd will be paid a dividend of $0.375 per share. This represents a $1.50 annualized dividend and a dividend yield of 1.63%. The ex-dividend date is Thursday, June 19th.
Several analysts have recently commented on the stock. Analysts at Deutsche Bank reiterated a “buy” rating on shares of Mead Johnson Nutrition CO in a research note on Monday, June 2nd. They now have a $99.00 price target on the stock, up previously from $97.00. Separately, analysts at Societe Generale raised their price target on shares of Mead Johnson Nutrition CO from $94.00 to $100.00 in a research note on Monday, April 28th. Three equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average target price of $95.26.
Mead Johnson Nutrition Company (NYSE:MJN) is a global pediatric nutrition company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.